scispace - formally typeset
G

Giuseppe Paolisso

Researcher at Seconda Università degli Studi di Napoli

Publications -  518
Citations -  36557

Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.

Papers
More filters
Journal ArticleDOI

Insulin resistance and executive dysfunction in older persons.

TL;DR: The association between insulin resistance (IR) and executive dysfunction in a large, population‐based study of older persons without diabetes mellitus (DM) or dementia is evaluated.
Journal ArticleDOI

Age-related insulin resistance : Is it an obligatory finding? The lesson from healthy centenarians

TL;DR: Only future longitudinal studies specifically designed to investigate the relationship between extreme old age and degree of insulin sensitivity will provide a conclusive answer with regard to the pathophysiology of adaptive metabolic changes occurring in the elderly.
Journal ArticleDOI

Body mass index is negatively associated with telomere length : a collaborative cross-sectional meta-analysis of 87 observational studies

Marij Gielen, +73 more
TL;DR: In this paper, a collaborative cross-sectional meta-analysis of observational studies was conducted to investigate the associations between BMI and leukocyte telomere length across the life span.
Journal ArticleDOI

Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients

TL;DR: A 4-week magnesium supplementation improves insulin sensitivity and glucose oxidation in the course of a euglycemic-hyperinsulinemic glucose clamp in noninsulin-dependent diabetic patients, suggesting that magnesium supplementation is useful in the management of type II diabetes.